Dietary supplement CDMO Sirio Pharma has invested approximately $17.4 million (€16 million) in a dedicated packaging facility, complete with automated packaging lines, at its Pritzwalk campus near Berlin.
The investment brings Sirio's total spend at the German site to close to $21 million over the last five years.
According to Sirio, the new facility enables the CDMO to offer customers a complete end-to-end solution, from formulation development to final product packaging. The facility is designed to ensure the seamless transfer of pharmaceutical and nutraceutical softgels from the adjacent manufacturing site, all operating under a unified pharmaceutical GMP standards regimen, approved for both human and veterinary medicinal products.
The new plant will offer two new bottling and blistering lines, supporting both bulk supply and private label options. The new packaging lines are equipped with advanced process-control technologies, including a fully automated bottling line with robotic palletization. According to Sirio, the packaging lines guarantee rapid processing, with production-to-delivery times as fast as three weeks.
The site boasts an overall bulk production capacity of 2 billion capsules per year.